友情提示:以下期刊信息可能会有更新,仅供参考,请在投稿前自行登录期刊官网仔细核实。
期刊名
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
INT J BIOL MARKER
ISSN / eISSN
0393-6155 / 1724-6008
目标和范围
The International Journal of Biological Markers (IJBM) is an international, online only, open access, peer-reviewed journal, which publishes original research and critical reviews primarily focused on cancer biomarkers.
IJBM targets advanced topics regarding the application of biomarkers in oncology and is dedicated to solid tumors in adult subjects. The clinical scenarios of interests are screening and early diagnosis of cancer, prognostic assessment, prediction of the response to and monitoring of treatment. The journal is interested in the publication of studies aimed at validation of biomarkers for clinical application.
In addition, IJBM focuses on research areas that facilitate translational research on biomarkers, such as knowledge translation, bio-banking, biostatistics and method validation and standardization.
研究方向
生物工程与应用微生物
肿瘤学
CiteScore
4.90
查看趋势图
CiteScore 学科排名
类别 | 分区 | 排名 |
---|---|---|
Medicine - Pathology and Forensic Medicine | Q2 | #50/193 |
Medicine - Oncology | Q2 | #165/366 |
Medicine - Clinical Biochemistry | Q2 | #57/113 |
Medicine - Cancer Research | Q3 | #130/214 |
Web of Science 核心合集
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
类别 (Journal Citation Reports 2023) | 分区 |
---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY - SCIE | Q4 |
ONCOLOGY - SCIE | Q4 |
H-index
38
出版国家或地区
ENGLAND
出版商
SAGE Publications Inc.
出版周期
Quarterly
出版年份
1986
年文章数
42
Open Access
YES
通讯方式
SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP
认证评论
28-Jan-2022 resubmitted after formatting
28-Mar-2022 minor revision
05-Apr-2022 received
29-Apr-2022 can be checked
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started